A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases

Clinical trial NCT00757757 · TERMINATED

Trial details

NCT number: NCT00757757
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Bone Metastases

Start date: 2008-09-01
Primary completion: 2009-08-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.